|

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

RECRUITINGSponsored by Johns Hopkins University
Actively Recruiting
SponsorJohns Hopkins University
Started2023-11-01
Est. completion2027-12-31
Eligibility
Age18 Years – 55 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06135870

Summary

The investigators are evaluating the role of senescent cells in uterine fibroids.

Eligibility

Age: 18 Years – 55 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Subjects must be women above the age of ≥18 - ≤55 years.
* Women with suspected uterine fibroids.
* Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.
* Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information.

Exclusion Criteria:

* Unwilling to sign the consent form or complete questionnaire.
* Pregnancy.
* Cancer of the uterus

Conditions3

CancerFibroidLeiomyoma

Locations1 site

Johns Hopkins Hospital
Baltimore, Maryland, 21287
Rachel Mitchelrmiche10@jhmi.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.